Occurrence of the JAK2 V617F mutation in the Buddg-Chiari syndrome

Donatella Colaizzo, Lucio Amitrano, Giovanni L. Tiscia, Luigi Iannaccone, Anna Gallone, Elvira Grandone, Maria A. Guardascione, Maurizio Margaglione

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Myeloproliferative diseases represent a major risk factor for Buddg-Chiari syndrome. In 32 patients with Buddg-Chiari syndrome, the JAK2 V617F mutation was detected, in heterozygous state, in 11 individuals (34.4%; 95% confidence interval: 18.6g-53.2). Eight patients with (72.7%; 95% confidence interval: 39.0g-94.0) and six without (28.6%; 95% confidence interval: 11.3g-52.2) the JAK2 V617F mutation had a diagnosis of myeloproliferative diseases before or at the occurrence of the venous thrombotic event. In three patients carrying the JAK2 V617F mutation, a myeloproliferative disease was not detected. Determination of the JAK2 V617F mutation may be useful to recognize patients with Buddg-Chiari syndrome with or at risk for the subsequent development of overt myeloproliferative diseases.

Original languageEnglish
Pages (from-to)459-462
Number of pages4
JournalBlood Coagulation and Fibrinolysis
Volume19
Issue number5
DOIs
Publication statusPublished - Jul 2008

Fingerprint

Budd-Chiari Syndrome
Mutation
Confidence Intervals

Keywords

  • AK2 V617F mutation
  • BuddChiari syndrome
  • Myeloproliferative disease
  • Thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Occurrence of the JAK2 V617F mutation in the Buddg-Chiari syndrome. / Colaizzo, Donatella; Amitrano, Lucio; Tiscia, Giovanni L.; Iannaccone, Luigi; Gallone, Anna; Grandone, Elvira; Guardascione, Maria A.; Margaglione, Maurizio.

In: Blood Coagulation and Fibrinolysis, Vol. 19, No. 5, 07.2008, p. 459-462.

Research output: Contribution to journalArticle

Colaizzo, Donatella ; Amitrano, Lucio ; Tiscia, Giovanni L. ; Iannaccone, Luigi ; Gallone, Anna ; Grandone, Elvira ; Guardascione, Maria A. ; Margaglione, Maurizio. / Occurrence of the JAK2 V617F mutation in the Buddg-Chiari syndrome. In: Blood Coagulation and Fibrinolysis. 2008 ; Vol. 19, No. 5. pp. 459-462.
@article{e079c62126f44cd4b32b5fc6a7b326d2,
title = "Occurrence of the JAK2 V617F mutation in the Buddg-Chiari syndrome",
abstract = "Myeloproliferative diseases represent a major risk factor for Buddg-Chiari syndrome. In 32 patients with Buddg-Chiari syndrome, the JAK2 V617F mutation was detected, in heterozygous state, in 11 individuals (34.4{\%}; 95{\%} confidence interval: 18.6g-53.2). Eight patients with (72.7{\%}; 95{\%} confidence interval: 39.0g-94.0) and six without (28.6{\%}; 95{\%} confidence interval: 11.3g-52.2) the JAK2 V617F mutation had a diagnosis of myeloproliferative diseases before or at the occurrence of the venous thrombotic event. In three patients carrying the JAK2 V617F mutation, a myeloproliferative disease was not detected. Determination of the JAK2 V617F mutation may be useful to recognize patients with Buddg-Chiari syndrome with or at risk for the subsequent development of overt myeloproliferative diseases.",
keywords = "AK2 V617F mutation, BuddChiari syndrome, Myeloproliferative disease, Thrombosis",
author = "Donatella Colaizzo and Lucio Amitrano and Tiscia, {Giovanni L.} and Luigi Iannaccone and Anna Gallone and Elvira Grandone and Guardascione, {Maria A.} and Maurizio Margaglione",
year = "2008",
month = "7",
doi = "10.1097/MBC.0b013e3283049662",
language = "English",
volume = "19",
pages = "459--462",
journal = "Blood Coagulation and Fibrinolysis",
issn = "0957-5235",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Occurrence of the JAK2 V617F mutation in the Buddg-Chiari syndrome

AU - Colaizzo, Donatella

AU - Amitrano, Lucio

AU - Tiscia, Giovanni L.

AU - Iannaccone, Luigi

AU - Gallone, Anna

AU - Grandone, Elvira

AU - Guardascione, Maria A.

AU - Margaglione, Maurizio

PY - 2008/7

Y1 - 2008/7

N2 - Myeloproliferative diseases represent a major risk factor for Buddg-Chiari syndrome. In 32 patients with Buddg-Chiari syndrome, the JAK2 V617F mutation was detected, in heterozygous state, in 11 individuals (34.4%; 95% confidence interval: 18.6g-53.2). Eight patients with (72.7%; 95% confidence interval: 39.0g-94.0) and six without (28.6%; 95% confidence interval: 11.3g-52.2) the JAK2 V617F mutation had a diagnosis of myeloproliferative diseases before or at the occurrence of the venous thrombotic event. In three patients carrying the JAK2 V617F mutation, a myeloproliferative disease was not detected. Determination of the JAK2 V617F mutation may be useful to recognize patients with Buddg-Chiari syndrome with or at risk for the subsequent development of overt myeloproliferative diseases.

AB - Myeloproliferative diseases represent a major risk factor for Buddg-Chiari syndrome. In 32 patients with Buddg-Chiari syndrome, the JAK2 V617F mutation was detected, in heterozygous state, in 11 individuals (34.4%; 95% confidence interval: 18.6g-53.2). Eight patients with (72.7%; 95% confidence interval: 39.0g-94.0) and six without (28.6%; 95% confidence interval: 11.3g-52.2) the JAK2 V617F mutation had a diagnosis of myeloproliferative diseases before or at the occurrence of the venous thrombotic event. In three patients carrying the JAK2 V617F mutation, a myeloproliferative disease was not detected. Determination of the JAK2 V617F mutation may be useful to recognize patients with Buddg-Chiari syndrome with or at risk for the subsequent development of overt myeloproliferative diseases.

KW - AK2 V617F mutation

KW - BuddChiari syndrome

KW - Myeloproliferative disease

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=59949094293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59949094293&partnerID=8YFLogxK

U2 - 10.1097/MBC.0b013e3283049662

DO - 10.1097/MBC.0b013e3283049662

M3 - Article

VL - 19

SP - 459

EP - 462

JO - Blood Coagulation and Fibrinolysis

JF - Blood Coagulation and Fibrinolysis

SN - 0957-5235

IS - 5

ER -